Derpan raises €2 million in bond sale

Business Forum
The initial offer of €1.8 million was oversubscribed 1.19 times, leading to a total of €2 million being raised, according to Goldring, which brokered the transaction.

The bonds, denominated in EUR, are secured and have an annual interest rate of 11% with a 2030 maturity.

The funds will be used to increase the utilisation of new production facilities, raising the capacity from 67% in 2025 to an estimated 86% by 2029.

The offering ran from August 6 to August 20, and the bonds are set to be listed on the BVB. The bonds are secured by a first-ranking movable mortgage on the Elmas brands owned by Golden Foods Snacks and Derpan.

Derpan owns two factories with a capacity of over eleven million croissants per month and more than 400 employees. The company distributes products under its own Elmas brand as well as private labels, with a strong presence in both modern and traditional retail. It also has partnerships with major retailers and is actively distributing in Central and Western Europe.

Derpan is projected to achieve a turnover of RON 124.1 million (€24.94 million) this year, marking a 28% increase from 2024. Net profit is estimated to double to RON 1.82 million (€365,800), up from RON 0.91 million (€182,900) in the previous year.

RECOMMENDED
BVB appoints new CEO
Finance

BVB appoints new CEO

Remus Vulpescu will be the new CEO of the Bucharest Stock Exchange (BVB) starting this summer, following a board decision

RECOMMENDED FROM THE HOME PAGE
IFC to acquire 10% stake in Romanian pension firm Carpathia
Finance

IFC to acquire 10% stake in Romanian pension firm Carpathia

The International Finance Corporation (IFC), a member of the World Bank Group, has signed an agreement with Vienna Insurance Group (VIG) to acquire approximately 10% of the shares of Carpathia Pensii, a Romanian private pension company.

Industry

Polpharma to launch takeover bid for Biofarm

Polish pharmaceutical company Zakłady Farmaceutyczne Polpharma has agreed to launch a voluntary public takeover offer (VTO) for all shares of Romanian drugmaker Biofarm, according to a regulatory filing.

READ MORE
Business Forum  |  8 May, 2026 at 7:03 PM
Business Forum  |  8 May, 2026 at 6:00 PM